Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
965.65
|
|
Change (%)
|
-8.95 (-0.92%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
960.30
-
975.05
|
|
52-Week Range (RS)
|
783.75
-
1,250.00
|
|
Beta (1 Year)
|
0.71
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| USFDA inspects Jubilant HollisterStier LLC's contract manufacturing unit located at Spokane |
| Jubilant Pharmova's Spokane facility gets USFDA inspection with 8 observations |
| Jubilant Pharmova fixes record date for final dividend |
| Board of Jubilant Pharmova recommends final dividend |
| Jubilant Pharmova consolidated net profit declines 22.27% in the March 2026 quarter |
| Jubilant Pharmova to convene board meeting |
| Paras Defence and Space Technologies Ltd leads losers in 'A' group |
| Jubilant Pharmova consolidated net profit declines 44.60% in the December 2025 quarter |
| Jubilant Pharmova slips after weak Q3 performance |
| Jubilant Pharmova to declare Quarterly Results |
|
|
|
| Incoporation Year : 1978 |
| Chairman : Shyam S Bhartia |
| Ownership Group : Jubilant Bhartia |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs |
| Registered Office |
Jubilant Pharmova Ltd
Bhartiagram Gajraula,
,
Amroha,
Uttar Pradesh-244223 |
Phone:91-5924-267200
Fax:91-5924-4264895/96 |
| E-Mail : investors@jubl.com |
| URL : http://www.jubl.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
12-Jun-2026 |
975.30 |
-0.99 |
| 1Month |
19-May-2026 |
1011.30 |
-4.51 |
| 3Month |
19-Mar-2026 |
850.45 |
13.55 |
| 6Month |
19-Dec-2025 |
1086.85 |
-11.15 |
| 1Year |
19-Jun-2025 |
1126.60 |
-14.29 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Bandhan Small Cap Fund |
1.31 |
356.07 |
| Quant Small Cap Fund |
0.92 |
293.24 |
| Kotak Multicap Fund |
0.71 |
186.46 |
| Bandhan Focused Fund |
5.42 |
110.85 |
| Kotak Special Opportunites Fund |
4.29 |
61.09 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Divis Laboratories Ltd |
6,741.15 |
-0.38 |
7,077.70 |
5,637.50 |
178,956.35 |
| Acutaas Chemicals Ltd |
3,243.95 |
3.44 |
3,442.40 |
1,059.05 |
26,558.58 |
| Neuland Laboratories Ltd |
17,349.60 |
0.80 |
19,748.40 |
11,500.00 |
22,259.34 |
| Dishman Pharmaceuticals and Chemicals Ltd(Merged) |
301.05 |
0.00 |
0.00 |
0.00 |
4,858.77 |
| Gujarat Themis Biosyn Ltd |
383.15 |
2.87 |
479.45 |
225.75 |
4,175.00 |
|
|
|
|